Induction of tumor-cell lysis by bi-spec
โ
J. Van Duk; S. O. Warnaar; J. D. H. Van Eendenburg; M. Thienpont; E. Braakman; J
๐
Article
๐
1989
๐
John Wiley and Sons
๐
French
โ 644 KB
## Bi -specific monoclonal antibodies (MAbs) were developed by somatic hybridization of 2 mouse hybridomas, one producing MAb against the G250 renal-cell carcinoma (RCC)-associated antigen and the other against the T-cell antigen CD3 (OKT3). The dual specificity of the hybrid MAb produced by these